Your browser doesn't support javascript.
loading
A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
Wang, Jing; Zhang, Hanxi; Lv, Jiazhen; Zheng, Yue; Li, Mengyue; Yang, Geng; Wei, Xiaodan; Li, Ningxi; Huang, Honglin; Li, Tingting; Qin, Xiang; Li, Shun; Wu, Chunhui; Zhang, Wei; Liu, Yiyao; Yang, Hong.
Afiliação
  • Wang J; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Zhang H; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Lv J; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Zheng Y; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Li M; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Yang G; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Wei X; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Li N; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Huang H; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Li T; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Qin X; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Li S; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Wu C; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.
  • Zhang W; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China. Electronic address: zhangweigk@med.uestc.edu.cn.
  • Liu Y; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China; TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Tr
  • Yang H; Department of Orthopedics, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China. Electronic address: yanghongyh@uestc.edu.cn.
Acta Biomater ; 164: 522-537, 2023 07 01.
Article em En | MEDLINE | ID: mdl-37072069

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: Acta Biomater Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: Acta Biomater Ano de publicação: 2023 Tipo de documento: Article